Crossmark

FITC-conjugated single chain Nimotuzumab can specifically recognize and enter EGFR-overexpressing cells

Published Online: 2022-03-22

Published Print: 2022-05

Authors

Hamidi, Seyedeh Roghayeh

Safdari, Yaghoub https://orcid.org/0000-0002-7515-2186
Sheikh Arabi, Mehdi
License Information

Text and Data Mining valid from 2022-03-22

Version of Record valid from 2022-03-22
More Information

Article History

Received: 11 February 2022

Revised: 28 February 2022

Accepted: 4 March 2022

First Online: 22 March 2022

Statements and Declarations

: There are no conflicts of interests to declare.

Document is current